In the hands of a minimally invasive gynecologic surgeon, women with advanced endometriosis do not have an increased risk of complications, according to the results of a retrospective study presented month at the 46th AAGL Global Congress on Minimally Invasive Gynecology.
Results of a Chinese study of the progestin dienogest build on data from a multicenter European study of the progestin in teens with endometriosis.
Women with endometriosis at first singleton pregnancy are about 1.5 times more likely to have a preterm birth (PTB), according to a meta-analysis.
A retrospective analysis of pregnancy outcomes suggests that a GnRH-agonist rather than a GnRH-antagonist protocol may be beneficial in women with endometriosis-related infertility.
Data from more than 1.9 million subjects shows that women with endometriosis have a statistically higher risk of obstetric complications including preterm birth (PTB) than those without the condition.
A new analysis of data from Nurses’ Health Study II (NHS II) shows that following the American College of Obstetricians and Gynecologists’ recommendations on breastfeeding may lower a woman’s risk of endometriosis. The association between the risk reduction and breastfeeding, the authors say, may be mediated at least in part by amenorrhea
Results of a new prospective cohort study add to existing literature on the association between endometriosis and skin cancer and show that the connection is strongest for melanoma. The findings, published in Cancer Causes and Control, are by researchers from the United States and France.
A recent study determined that magnetic resonance imaging (MRI) and rectal endoscopic sonography (RES) are of significant, but different value in determining the presence and depth of deep infiltrating endometriosis (DIE).
Results of an online survey show that the type and severity of a woman’s endometriosis symptoms has a significant relationship with her productivity both at work and at home.
Results of a small new trial performed in a pediatric gynecology clinic show that an endometriosis therapy previously studied only in adults may be effective for teens. The findings reflect outcomes for quality of life in adolescents treated with “add-back” therapy with norethindrone acetate (NA) plus conjugated estrogens (CEE) versus NA alone.